IS5990A - Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar - Google Patents

Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar

Info

Publication number
IS5990A
IS5990A IS5990A IS5990A IS5990A IS 5990 A IS5990 A IS 5990A IS 5990 A IS5990 A IS 5990A IS 5990 A IS5990 A IS 5990A IS 5990 A IS5990 A IS 5990A
Authority
IS
Iceland
Prior art keywords
thrombin inhibitors
benzylamine derivatives
new amidine
amidine
new
Prior art date
Application number
IS5990A
Other languages
English (en)
Inventor
Inghardt Tord
Nyström Jan-Erik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9900071A external-priority patent/SE9900071D0/xx
Priority claimed from SE9904228A external-priority patent/SE9904228D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5990A publication Critical patent/IS5990A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
IS5990A 1999-01-13 2001-07-05 Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar IS5990A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9900071A SE9900071D0 (sv) 1999-01-13 1999-01-13 New compounds
SE9904228A SE9904228D0 (sv) 1999-11-22 1999-11-22 New compounds
PCT/SE2000/000052 WO2000042059A1 (en) 1999-01-13 2000-01-13 New amidinobenzylamine derivatives and their use as thrombin inhibitors

Publications (1)

Publication Number Publication Date
IS5990A true IS5990A (is) 2001-07-05

Family

ID=26663479

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5990A IS5990A (is) 1999-01-13 2001-07-05 Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar

Country Status (22)

Country Link
US (1) US6599894B1 (is)
EP (1) EP1150996B1 (is)
JP (1) JP2002535250A (is)
KR (1) KR100639274B1 (is)
CN (1) CN1170842C (is)
AU (1) AU764121B2 (is)
BR (1) BR0007453A (is)
CA (1) CA2355792A1 (is)
CY (1) CY1107149T1 (is)
CZ (1) CZ20012529A3 (is)
DE (1) DE60037183T2 (is)
DK (1) DK1150996T3 (is)
EE (1) EE200100371A (is)
ES (1) ES2295004T3 (is)
IL (1) IL143987A (is)
IS (1) IS5990A (is)
NO (1) NO20013319L (is)
NZ (1) NZ512714A (is)
PL (1) PL349769A1 (is)
PT (1) PT1150996E (is)
TR (1) TR200102037T2 (is)
WO (1) WO2000042059A1 (is)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
EP1311480B1 (en) * 2000-08-16 2008-09-03 AstraZeneca AB New amidino derivatives and their use as thrombin inhibitors
US6433186B1 (en) * 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
SE0102921D0 (sv) * 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
US7129233B2 (en) * 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
RU2300521C2 (ru) * 2000-12-01 2007-06-10 Астразенека Аб Новые производные миндальной кислоты и их применение в качестве ингибиторов тромбина
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
EP1432687A2 (en) * 2001-10-03 2004-06-30 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
SE0201661D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
CA1341029C (en) 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897515B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (is) 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
CZ333492A3 (en) 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
JPH08501057A (ja) 1992-03-04 1996-02-06 ヂョヂセルクタトー インテーゼット カーエフテー 新規な抗凝結因子ペプチド誘導体及びそれを含有する製薬学的組成物及びその製造方法
TW223629B (is) 1992-03-06 1994-05-11 Hoffmann La Roche
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
AU1025795A (en) 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
US5707966A (en) 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5705487A (en) 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
ZA951617B (en) 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
DE4421052A1 (de) 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
CZ245797A3 (cs) 1995-02-17 1998-06-17 Basf Aktiengesellschaft Derivát amidinu dipeptidu jako inhibitor thrombinu
US5710130A (en) 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
AU698911B2 (en) 1995-04-04 1998-11-12 Merck & Co., Inc. Thrombin inhibitors
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
TWI238827B (en) 1995-12-21 2005-09-01 Astrazeneca Ab Prodrugs of thrombin inhibitors
AU1990197A (en) 1996-03-12 1997-10-01 Bristol-Myers Squibb Company Carbamyl guanidine and amidine prodrugs
SE9602263D0 (sv) * 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
CA2258915A1 (en) 1996-06-25 1997-12-31 Michael Robert Wiley Anticoagulant agents
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados

Also Published As

Publication number Publication date
JP2002535250A (ja) 2002-10-22
AU2336200A (en) 2000-08-01
EP1150996A1 (en) 2001-11-07
CA2355792A1 (en) 2000-07-20
IL143987A (en) 2005-12-18
DK1150996T3 (da) 2008-02-11
AU764121B2 (en) 2003-08-07
NO20013319D0 (no) 2001-07-04
DE60037183T2 (de) 2008-10-09
CN1343217A (zh) 2002-04-03
CY1107149T1 (el) 2012-10-24
US6599894B1 (en) 2003-07-29
WO2000042059A1 (en) 2000-07-20
NZ512714A (en) 2003-10-31
TR200102037T2 (tr) 2001-10-22
ES2295004T3 (es) 2008-04-16
NO20013319L (no) 2001-09-12
KR100639274B1 (ko) 2006-10-27
CZ20012529A3 (cs) 2001-11-14
EE200100371A (et) 2002-02-15
CN1170842C (zh) 2004-10-13
EP1150996B1 (en) 2007-11-21
KR20010101493A (ko) 2001-11-14
DE60037183D1 (de) 2008-01-03
BR0007453A (pt) 2001-10-30
PL349769A1 (en) 2002-09-09
IL143987A0 (en) 2002-04-21
PT1150996E (pt) 2008-01-15

Similar Documents

Publication Publication Date Title
IS6656A (is) Útskiptar kínasólínafleiður og notkun þeirra sem hemla
IS5302A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
IS4930A (is) Nýjar amidínóafleiður og notkun þeirra sem þrombínhemla
IS6828A (is) Nýjar afleiður möndlusýru og notkun þeirra sem þrombínhemla
IS6264A (is) Arýlmetýl-karbónýlamínó-þíósól afleiður og notkunþeirra sem miðla gegn æxlum
NO20022656L (no) Caspaseinhibitorer og anvendelse derav
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
NO20012570D0 (no) Substituerte benzimidazoler og deres anvendelse som PARP- inhibitorer
IS7792A (is) Hýdantóínafleiður og notkun þeirra sem TACE hemla
IS5990A (is) Nýjar amidínbensýlamínafleiður og notkun þeirra sem þrombínhemlar
EE200100373A (et) Bensoheterotsüklid ja nende kasutamine MEK inhibiitoritena
IS4906A (is) Nýjar amínósýruafleiður og notkun þeirra sem þrombínhemla
PL356427A1 (en) Indol-3-yl derivatives and their use as integrin inhibitors
IL156214A0 (en) New guanidine and amidine derivatives as factor xa inhibitors
NO20014875L (no) Promedikamenter for trombin inhibitorer
NO20003814D0 (no) Trombininhibitorer
AU5693101A (en) New thiochromane derivatives and their use as thrombin inhibitors
ATE309211T1 (de) Amidino- und guanidino-azetidinone tryptase- inhibitoren
PT1189929E (pt) Inibidores do factor viia
DK1230227T3 (da) Benzoxa- og benzthiazolylsulfamater og anvendelse deraf som steroid-sulfataseinhibitorer
NO20025135L (no) Antihypertensive midler og anvendelse
SI1150996T1 (sl) Novi amidinobenzilaminski derivati in njihova uporaba kot trombinski inhibitorji
ZA200105277B (en) New amidinobenzylamine derivatives and their use as thrombin inhibitors.